Polyethylene Glycol 3350 is indicated for the treatment of occasional constipation. For more information, including Uses, Warnings and Directions, please refer to the product's Drug Facts. ANI ...

Ani Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 Powder for Oral Solution. Ani ...

According to Nielsen® syndicated data for the latest 52 weeks' period ending February 22, 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market 3 achieved annual sales of approximately $555.7 ...

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Polyethylene Glycol 3350, Powder for Solution 17 grams/capful and 17 grams/packet (OTC) According to ...

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte.,Singapore, has received approval for Polyethylene Glycol 3350 and Electrolytes for Oral Solution ...

BAUDETTE, Minn., March 26, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Polyethylene Glycol 3350, 17g/Packet (PEG-3350). The current annual ...

Glenmark Therapeutics Inc., USA (Glenmark) announced the launch of polyethylene glycol 3350, powder for solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX powder for solution ...

Polyethylene Glycol 3350 is indicated for the treatment of occasional constipation. For more information, including Uses, Warnings and Directions, please refer to the product's Drug Facts. ANI ...

Strides Shasun Ltd has informed BSE regarding a Press Release dated August 25, 2016 titled "Strides Shasun receives USFDA Approval for Polyethylene Glycol 3350, Powder for Solution (OTC)".Source : BSE ...

MAHWAH, N.J., March 10, 2025 /PRNewswire/ -- Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch 1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); ...